Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

technospeak.fr Blueprint · Rev.39

Sheet A · Product board

glutathione and nac benefits (N-Acetyl L-Cysteine) Supplement CJC (No DAC):10mg Vial + BAC Water 3ml Supplements G-P Supplement Store - VITAstir

Unit price

USD21.23

USD55.23

Pay in 4 interest-free payments of $5.31 Learn more

Field rating

4.5

Verified studio score · Spec revision current

Fit · Size

glutathione and nac benefits

glutathione and nac benefits (N-Acetyl L-Cysteine) Supplement CJC (No DAC):10mg Vial + BAC Water 3ml Supplements G-P Supplement Store - VITAstir

SKU: 25641792571

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 30 - Nov 4

Description

glutathione and nac benefits (N-Acetyl L-Cysteine) Supplement CJC (No DAC):10mg Vial + BAC Water 3ml Supplements G-P Supplement Store - VITAstir

Supplement Store - VITAstir Clinic

GHK-Cu is naturally found in trace amounts in human plasma, saliva, and urine

Supplements G-P

CJC (No DAC):10mg Vial + BAC Water 3ml

doi: 10.1177/106002808401800902

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies

Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies

US$ 26.42

4.7 (13 reviews)

In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma

In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma

US$ 21.54

4.7 (22 reviews)

Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy

Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy

US$ 21.13

4.3 (17 reviews)

Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis

Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis

US$ 22.78

4.3 (7 reviews)

Frontiers

Frontiers

US$ 20.27

4.3 (13 reviews)

Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse: Cell Reports Medicine

Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse: Cell Reports Medicine

US$ 29.34

4.1 (11 reviews)

JCI Insight

JCI Insight

US$ 21.34

4.3 (25 reviews)

Ferroptosis: Opportunities and Challenges in Cancer

Ferroptosis: Opportunities and Challenges in Cancer

US$ 26.60

4.9 (6 reviews)

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells - Song - 2023 - MedComm

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells - Song - 2023 - MedComm

US$ 23.99

4.8 (22 reviews)

Plasticity, signaling, and metabolic rewiring in melanoma persister cells

Plasticity, signaling, and metabolic rewiring in melanoma persister cells

US$ 27.76

4.4 (24 reviews)

JCI

JCI

US$ 28.78

4.2 (21 reviews)

Frontiers

Frontiers

US$ 21.04

4.4 (28 reviews)

Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy | EMBO Molecular Medicine

Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy | EMBO Molecular Medicine

US$ 28.30

4.9 (7 reviews)

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation

US$ 25.21

4.3 (22 reviews)

Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy

Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy

US$ 25.29

4.7 (18 reviews)

Frontiers

Frontiers

US$ 22.87

4.1 (24 reviews)

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities

US$ 23.57

5.0 (28 reviews)

Persister cancer cells: Iron addiction and vulnerability to ferroptosis: Molecular Cell

Persister cancer cells: Iron addiction and vulnerability to ferroptosis: Molecular Cell

US$ 29.54

4.7 (23 reviews)

FSP1 and histone deacetylases suppress cancer persister cell ferroptosis

FSP1 and histone deacetylases suppress cancer persister cell ferroptosis

US$ 28.12

4.0 (10 reviews)

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

US$ 23.24

4.2 (28 reviews)